Chemed
425 hedge funds and large institutions have $6.6B invested in Chemed in 2021 Q2 according to their latest regulatory filings, with 62 funds opening new positions, 129 increasing their positions, 155 reducing their positions, and 53 closing their positions.
33% more call options, than puts
Call options by funds: $13.9M | Put options by funds: $10.4M
17% more first-time investments, than exits
New positions opened: 62 | Existing positions closed: 53
1% more funds holding
Funds holding: 421 → 425 (+4)
0% more capital invested
Capital invested by funds: $6.58B → $6.6B (+$16.3M)
2.16% less ownership
Funds ownership: 89.51% → 87.35% (-2.2%)
17% less repeat investments, than reductions
Existing positions increased: 129 | Existing positions reduced: 155
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BTW
Boston Trust Walden
Boston,
Massachusetts
|
+$33.2M |
| 2 |
Fidelity International
Hamilton,
Bermuda
|
+$31.7M |
| 3 |
Ninety One (UK)
London,
United Kingdom
|
+$31.5M |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
+$23.5M |
| 5 |
Kayne Anderson Rudnick Investment Management
Los Angeles,
California
|
+$22.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$46M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$44.8M |
| 3 |
Invesco
Atlanta,
Georgia
|
-$44.6M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$34.9M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
-$30.5M |
CHE Hedge Fund Activity: Q2 2021 in Review
425 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Chemed (CHE) for Q2 2021, worth a combined $6.6B — up 0.25% from $6.58B a quarter earlier.
Buyers outnumbered sellers: 62 funds opened new CHE positions and 53 closed out — a net gain of 9 holders — while 129 added to existing stakes and 155 trimmed.
The largest buyer was Boston Trust Walden, adding an estimated $33.2M. The largest seller was BlackRock, cutting an estimated $46M.
- 425 institutional investors held Chemed (CHE) as of Q2 2021, up from 421 in Q1 2021.
- Funds reported $6.6B of Chemed stock for Q2 2021, up 0.25% quarter-over-quarter.
- 62 funds opened new Chemed positions in Q2 2021 and 53 closed out, a net change of +9 holders.
- The largest Chemed buyer in Q2 2021 was Boston Trust Walden, an estimated $33.2M added.
- The largest Chemed seller in Q2 2021 was BlackRock, an estimated $46M sold.
Based on aggregated 13F filings for Q2 2021.